Buscar
-
Reduced dose of rivaroxaban and dabigatran vs. vitamin K antagonists in very elderly patients with atrial fibrillation in a nationwide cohort study
(EP-Europace. vol. 22, n° 2, pp. 205-215, 2020)Article de revue -
Epidemiology of metastatic castration-resistant prostate cancer: A first estimate of incidence and prevalence using the French nationwide healthcare database
(Cancer Epidemiology. vol. 69, pp. 101833, 2020)Article de revueLibre acceso -
Chloroquine for COVID-19 Infection
(Drug Safety. vol. 43, n° 3, pp. 393-394, 2020)Article de revue -
Comparative Real-Life Effectiveness and Safety of Dabigatran or Rivaroxaban vs. Vitamin K Antagonists: A High-Dimensional Propensity Score Matched New Users Cohort Study in the French National Healthcare Data System SNDS
(Am J Cardiovasc Drugs. vol. 20, n° 1, pp. 81-103, 2020)Article de revue -
Does Ibuprofen Worsen COVID-19?
(Drug Safety. vol. 43, n° 7, pp. 611-614, 2020)Article de revue -
No arguments for extra risk from ibuprofen in SARS-COV2 infection
(Thérapie. vol. 75, n° 5, pp. 513-514, 2020)Article de revue -
Considerations for pharmacoepidemiological analyses in the SARS-CoV-2 pandemic
(Pharmacoepidemiology and Drug Safety. vol. 29, n° 8, pp. 825-831, 2020)Article de revue -
Pharmacological treatment patterns in heart failure: a population-based cohort study
(Eur J Clin Pharmacol. vol. 76, n° 1, pp. 97-106, 2020)Article de revue -
The safety of agomelatine in standard medical practice in depressed patients: A 26-week international multicentre cohort study
(Human Psychopharmacology: Clinical and Experimental. pp. e2759, 2020-09-25)Article de revueLibre acceso -
Effectiveness and Safety of Standard and Reduced Doses of Dabigatran Compared to Rivaroxaban in Nonvalvular Atrial Fibrillation: Long-Term Results from a Cohort Study in the French Nationwide Claims Database
(Journal of the American College of Cardiology. vol. 75, n° 11, pp. 357, 2020)Article de revue